Most US breast augmentation patients choose silicone. But the more useful question is which one fits your body, your age, and your willingness to commit to long-term monitoring. This guide covers what most comparison pages skip: the imaging commitment, the age rule, the device history, and what the warranty actually buys you.
First, what actually differs, and what doesn't
Both implants use a silicone outer shell. Only the fill differs: cohesive silicone gel versus sterile saltwater. Saline implants are inserted empty and filled once in place; silicone implants arrive pre-filled, which is why they need a slightly longer incision (typically 4–5 cm).
What surprises most patients: there is no inherent safety gap between the fills. Both are FDA-approved, and surgeons describe no significant difference in the safety of silicone gel versus saline-filled implants. The choice is about feel, behavior, and maintenance, not about one being "safe" and the other "risky." [6]
Why most patients pick silicone: feel
The number-one reason patients choose silicone is feel. The cohesive gel is designed to mimic natural breast tissue, softer, with more natural movement. Saline feels firmer, and it ripples more visibly, especially in thin patients with little natural tissue coverage. If a natural feel is your priority, silicone wins the comparison for most bodies.
The commitment most pages skip: silent rupture and imaging
This is the factor that should drive the decision more than it does. If a saline implant ruptures, you know immediately. It deflates visibly, and the saltwater is harmlessly absorbed. If a silicone implant ruptures, it's often silent: the gel stays in or around the capsule, and you may notice nothing at all.
That means silicone comes with a long-term monitoring commitment. Current FDA/ACR guidance: a first ultrasound or MRI at 5–6 years after surgery, then every 2–3 years. Ultrasound is now an accepted screening option for asymptomatic patients; MRI remains the gold standard. A practical note the brochures skip: MRIs are often not covered for routine screening, so silicone's maintenance is a real long-term commitment to plan for. [1]
Choosing silicone means choosing this surveillance schedule. If you won't follow it, that's an honest argument for saline.
The age rule and the history behind it
The FDA sets a minimum age of 22 for cosmetic silicone augmentation and 18 for saline (both at any age for reconstruction). This isn't a suggestion. It's part of the device approval. If you're under 22 and set on augmentation, saline is the regulatory path. [6]
Today's silicone implants are fifth-generation devices, "cohesive" or "gummy bear" gel, introduced around 1993, with higher cross-linking that makes the gel form-stable (it holds its shape even if cut). But the word "cohesive" describes the gel only, not the shape or surface, and more cohesion means a firmer feel and a rupture that's less obvious.
The history matters: the FDA restricted silicone implants from 1992 to 2006, a 14-year moratorium, then re-approved them in November 2006 for ages 22+ after reviewing the core-study data. Silicone's share of US augmentations rose sharply in the years after re-approval. The devices you can get today are the product of that scrutiny. [6]
Warranty and safety questions, answered plainly
There are four FDA-approved manufacturers: Allergan Natrelle, Mentor, Sientra, and Motiva (the newest US approval). All offer lifetime free implant replacement in case of rupture. The differences are in the financial assistance toward revision surgery, which varies by manufacturer and time window, with capsular-contracture coverage varying. Read the warranty as what it is: device replacement plus partial surgical assistance, not a promise you'll never need another operation. [2]
Capsular contracture. The 10-year rates run roughly 9–13.5% depending on the study cohort, dropping as low as 1.8% with optimized technique (antibiotic irrigation). It's more common with over-the-muscle placement and larger implants. [3]
BIA-ALCL. A rare T-cell lymphoma of the scar capsule, not breast cancer, associated far more with textured implants; the fill doesn't change the risk. US lifetime risk estimates for textured devices range from 1 in 3,817 to 1 in 30,000. Median onset is 8–10 years; the hallmark is late swelling more than a year after surgery. The FDA does not recommend removing asymptomatic textured implants. [4]
Breast implant illness. The FDA includes systemic symptoms in the boxed warning but calls the causal connection "unclear at this time." A 2025 meta-analysis of 33 studies (6,048 patients) found average symptom onset at 6.4 years: fatigue (58.3%), joint pain (51%), muscle pain (44%), with 81.9% reporting improvement after explantation. There is no diagnostic test; it's a diagnosis of exclusion. Put plainly: the symptoms are real to the patients who report them, and the science is still clarifying the mechanism. [5]
The FDA's boxed warning also states plainly: implants are not lifetime devices, and complication risk rises the longer they're in. [6]
Which patient picks which?
Silicone suits the patient who prioritizes natural feel, has thin tissue coverage (less rippling), is 22 or older, and will commit to the ultrasound/MRI surveillance schedule.
Saline suits the patient under 22, the patient who wants rupture to be immediately obvious with no imaging schedule, or the patient who wants the smallest possible incision.
Neither choice is the "safe" one and the "risky" one. They're different maintenance profiles attached to different feels.
Decide like it's 20 years, because it is. Decide on silicone versus saline the way you'd decide on anything you'll live with for 15–20 years: feel first, then the fine print, the silent-rupture monitoring, the age rule, the warranty terms.
Frequently asked questions
Q: Why do most patients choose silicone?
A: Feel. The cohesive gel mimics natural breast tissue more closely, while saline feels firmer and ripples more visibly in thin patients. Most surgeons say the choice usually comes down to how natural the patient wants the result to feel.
Q: What is the imaging commitment with silicone?
A: A first ultrasound or MRI at 5 to 6 years after surgery, then every 2 to 3 years. MRIs are often not covered for routine screening. [1]
Q: What are the FDA age rules?
A: A minimum of 22 for cosmetic silicone augmentation and 18 for saline. It isn't a suggestion; it's part of the device approval. [6]
Q: What does the warranty actually cover?
A: All four manufacturers offer lifetime free implant replacement for rupture. Financial assistance toward revision surgery differs by manufacturer and time window, with capsular-contracture coverage varying. [2]
Q: What are the BIA-ALCL risk numbers?
A: BIA-ALCL is a rare T-cell lymphoma of the scar capsule associated far more with textured implants; the fill doesn't change the risk. US lifetime risk estimates for textured devices range from 1 in 3,817 to 1 in 30,000, with median onset at 8 to 10 years. [4]
Sources
https://www.jacr.org/article/S1546-1440(26)00035-9/abstract
https://www.realself.com/news/breast-implant-brand-differences
https://pubmed.ncbi.nlm.nih.gov/25717116/
https://practicaldermatology.com/topics/skin-cancer-photoprotection/an-update-on-breast-implant-associated-anaplastic-large-cell-lymphoma/22995/
https://link.springer.com/article/10.1007/s00266-025-05142-x
At Nip Tuck Aesthetics, this decision framework with Dr. Michael Stefan includes the long-term imaging commitment most consultations gloss over. Nip Tuck Aesthetics is at 8501 SW 124 Ave Suite #317, Miami, FL 33183. Book a consultation and choose with the full picture in front of you.
Learn more about related procedures at Nip Tuck Aesthetics and discuss your options during a consultation.
FINANCING AVAILABLE -